Cargando…

Increased ABCC2 expression predicts cisplatin resistance in non‐small cell lung cancer

Long‐term use of platinum‐based drugs can cause non‐small cell lung cancer (NSCLC) to develop extremely strong drug resistance. Increasing the drug dosage does not have better treatment effects and could lead to serious complications. High levels of drug resistance are considered to be characteristi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yun, Zhou, Hongying, Yang, Sifu, Su, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983913/ https://www.ncbi.nlm.nih.gov/pubmed/32815556 http://dx.doi.org/10.1002/cbf.3577

Ejemplares similares

PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer In Vitro and In Vivo
por: Chen, Yun, et al.
Publicado: (2020)

EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis
por: Fan, Chi-Chen, et al.
Publicado: (2020)

ABCC3 as a marker for multidrug resistance in non-small cell lung cancer
por: Zhao, Yanbin, et al.
Publicado: (2013)

Identification of circ_0058357 as a regulator in non‐small cell lung cancer cells resistant to cisplatin by miR‐361‐3p/ABCC1 axis
por: Chu, Dan, et al.
Publicado: (2021)

Bixin and Fuxoxanthin Alone and in Combination with Cisplatin Regulate ABCC1 and ABCC2 Transcription in A549 Lung Cancer Cells
por: Chandra, Ferdy, et al.
Publicado: (2023)

Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer
por: Cui, Yong, et al.
Publicado: (2018)

Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway
por: Chen, Yun, et al.
Publicado: (2020)

ABCC4 is required for cell proliferation and tumorigenesis in non-small cell lung cancer
por: Zhao, Xiaoting, et al.
Publicado: (2014)

The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer
por: Zhao, Jian, et al.
Publicado: (2015)

ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines
por: Weaver, David A, et al.
Publicado: (2005)

Predictable Resistance and Overall Survival of Gemcitabine/Cisplatin by Platelet Activation Index in Non-Small Cell Lung Cancer
por: Shi, Liang, et al.
Publicado: (2018)

Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways
por: Sun, Chao-Yue, et al.
Publicado: (2018)

Downregulation of exosomal miR-1273a increases cisplatin resistance of non-small cell lung cancer by upregulating the expression of syndecan binding protein
por: Zhao, Xiaolong, et al.
Publicado: (2020)

Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma
por: Zhang, Youwei, et al.
Publicado: (2020)

SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer
por: SHEN, LIHUA, et al.
Publicado: (2016)

Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
por: Xu, Jie, et al.
Publicado: (2014)

MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
por: Fadejeva, Irina, et al.
Publicado: (2017)

EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations
por: Gao, Jing, et al.
Publicado: (2016)

Bile Acids Increase Doxorubicin Sensitivity in ABCC1-expressing Tumour Cells
por: Chewchuk, Simon, et al.
Publicado: (2018)

Increased Expression of Plasma-Induced ABCC1 mRNA in Cystic Fibrosis
por: Ideozu, Justin E., et al.
Publicado: (2017)

Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798
por: Yang, Xuemei, et al.
Publicado: (2017)

WP1130 attenuates cisplatin resistance by decreasing P53 expression in non–small cell lung carcinomas
por: Wang, Xiang, et al.
Publicado: (2017)

Overexpression of ABCC1 Confers Drug Resistance to Betulin
por: Chen, Xuan-Yu, et al.
Publicado: (2021)

Lentivirus-mediated RNAi silencing targeting ABCC2 increasing the sensitivity of a human nasopharyngeal carcinoma cell line against cisplatin
por: Xie, Si Ming, et al.
Publicado: (2008)

Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
por: Xiao, Lu, et al.
Publicado: (2017)

Overexpression of MRP1/ABCC1, Survivin and BCRP/ABCC2 Predicts the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Treatment
por: Mandić, Danijela, et al.
Publicado: (2023)

Functional Expression of Multidrug Resistance Protein 4 MRP4/ABCC4
por: Hardy, David, et al.
Publicado: (2019)

MMP9 Expression Correlates With Cisplatin Resistance in Small Cell Lung Cancer Patients
por: Wu, Longqiu, et al.
Publicado: (2022)

Increased ABCC4 Expression Induced by ERRα Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer
por: Huang, Houbao, et al.
Publicado: (2020)

Three novel ABCC5 splice variants in human retina and their role as regulators of ABCC5 gene expression
por: Stojic, Jelena, et al.
Publicado: (2007)

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
por: Stathopoulos, G. P., et al.
Publicado: (2011)

CDH13 promoter methylation regulates cisplatin resistance of non-small cell lung cancer cells
por: Wang, Yan, et al.
Publicado: (2018)

Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells
por: Li, Amin, et al.
Publicado: (2020)

The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells
por: Guo, Jiwei, et al.
Publicado: (2018)

Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children
por: Pussegoda, K, et al.
Publicado: (2013)

Applications of Machine Learning to Predict Cisplatin Resistance in Lung Cancer
por: Gao, Yanan, et al.
Publicado: (2021)

Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells
por: Zhou, Huiling, et al.
Publicado: (2023)

Increased efficacy of gefitinib on cisplatin-resistant wild-type epidermal growth factor receptor non-small cell lung cancer cells
por: Li, Amin, et al.
Publicado: (2020)

The Noncoding RNA Expression Profile and the Effect of lncRNA AK126698 on Cisplatin Resistance in Non-Small-Cell Lung Cancer Cell
por: Yang, Yong, et al.
Publicado: (2013)

GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin
por: Gong, Xin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_83i7hrftgfoejmonqlu9dkdlpr